Skip to main content

Chronic disease at core of Big Apple COVID-19 deaths

A recent summary of COVID-19-related deaths in New York City confirms the much higher mortality risks among those with underlying health conditions.  Among the >80% of fatalities for which underlying condition status was known, only 0.8% of those dying had no chronic disease. 

As we know from prior reports, obesity, diabetes, high blood pressure and heart disease are underlying conditions very frequently associated with novel coronavirus deaths. Furthermore, chronic diseases make up the vast majority of "underlying conditions" among those who die.  (See earlier blog post.) 

This pandemic has been another wake-up call on the continued dangers of failing to prevent the widespread inactivity & unhealthy nutrition leading to epidemic chronic disease.  Will we start making a serious effort to develop healthy habits, particularly K-12?  Or will we continue to hit the snooze button as health worsens?

Comments

Popular posts from this blog

Citizen-ready civics: the powerful synergy of knowledge plus engagement

Boy, am I an infrequent blogger!  I do want to assure you, though, that I am alive and working on our focus areas.  In particular, there is a window of opportunity opening in the "life-ready" area in Arizona.   The Arizona Department of Health Services has recently determined, after a comprehensive statewide review process, that obesity is the number one health issue facing Arizona.  Other preventable chronic conditions such as heart disease and diabetes were also identified as major AZ health issues. Furthermore, we already know that four of the five root causes of the vast majority of these conditions are unhealthy nutrition, lack of physical activity, smoking, and excess drinking.  (Genetics plays a role as well, but healthy behavior can often trump genetics.)   At the same time, a number of organizations and individuals are frustrated by the increasing narrowing of our public K-12 education, and the dire consequences of downplaying social studies and health educ

Is it a “Miracle Drug”?...if it Costs a Fortune and Creates Lifelong Dependency...&...Saggy Faces!?

[It’s been a while since our last blog post.  A lot has happened since– including some “miracles” ! So we’re going to do two posts in a row…] Normally we should all be happy about miracle drugs... shouldn't we ? Yes, there is lots of upside from taking semaglutide (Ozempic, Wegovy), tirzepatide (Montjaro)--and upcoming new, even-more-miraculous drugs TBD:  losing huge amounts of weight quickly, a much lower risk of diabetes–and probably less heart disease and other chronic conditions as well.  But what if the “miracle” requires:   $200-300/week, with a lifetime cost of hundreds of thousands of dollars…  a drug that you can never quit…because if you stop taking it, you gain back all the weight it helped you lose–not to mention the chronic diseases which the drugs kept at bay… and it leaves your face (and the rest of your skin?) sagging …    (plus, it’s so new at such high dosages– who knows what happens after years of use…? ) No doubt, in spite of this--many people with severe obesi

Health Horror Shows--Sequels Even Worse!!

The recent health news double-feature was really scary: 1.  40% of Adults Obese 2.  1 in 5 Adolescents with Prediabetes Then came the even-more-shocking news on the “sequels”: For adults: “ Severe obesity  is likely to become the most common BMI category among...low-income adults”--  close to 1 in 3 >75-100 pounds overweight by 2030 --when about 50% of adults will be obese nationwide . For teens with prediabetes:  “However, compared with adults, decline in β-cell function seems to occur at an accelerated rate resulting in relative insulin deficiency and progression to overt type 2 diabetes  with insulin treatment needed to control hyperglycemia within a few years after diagnosis .” Let us be clear what this means: High child obesity (~20% nationally now) is leading to very high adult obesity (40% now, going to 50%+) and  severe obesity (1 in 12 adults now, going to 1 in 4 in 2030 ). Unlike typical adult-onset diabetes